iRhythm Holdings, Inc.

IRTC ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-44.6M $-113.3M $-123.4M $-116.2M $-101.4M $-43.8M $-54.6M $-50.4M
Depreciation & Amortization $20.7M $20.7M $16.3M $13.4M $9.8M $6.9M $3.4M $2.3M
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $88.3M $76.0M $77.2M $57.7M $54.5M $41.5M $26.2M $16.3M
Net Cash from Operating Activities $80.9M $3.4M $-50.1M $-23.0M $-37.8M $-13.8M $-21.9M $-29.1M
Investing Activities
Capital Expenditures $46.3M $33.9M $40.4M $29.8M $28.1M $13.6M $20.5M $5.2M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-277.1M $-123.0M $-1.2M $-52.4M $105.3M $-132.4M $-89.3M $34.1M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $0 $25.0M $0 $0 — — — —
Net Cash from Financing Activities $12.6M $511.4M $8.8M $26.7M $-28.6M $214.3M $111.6M $6.3M
Net Change in Cash $-183.6M $391.8M $-42.7M $-48.7M $38.9M $68.2M $439.0K $11.4M
Free Cash Flow $34.5M $-30.6M $-90.5M $-52.8M $-65.8M $-27.3M $-42.3M $-34.3M
← Newer Page 1 of 2 Older →